John M. Pascal, Thomas Jefferson University (IMAGE)

Thomas Jefferson University

John M. Pascal, Thomas Jefferson University

Caption

An investigation led by John M. Pascal, Ph.D., an assistant professor in the Department of Biochemistry and Molecular Biology at Thomas Jefferson University and Jefferson's Kimmel Cancer Center, revealed new target sites for drugs aiming to stop PARP-1 activity.

Credit

Thomas Jefferson University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.